Picture of AVITA Medical logo

RCEL AVITA Medical Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual cashflow statement for AVITA Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
June 30th
2021
June 30th
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M
Source:10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinal
Net Income/Starting Line-42-26.6-26.7-35.4
Depreciation
Non-Cash Items17.57.328.23.31
Unusual Items
Other Non-Cash Items
Changes in Working Capital1.33-7.36-1.2-6.57
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities-22.7-25.9-19.1-38
Capital Expenditures-0.847-1.17-0.452-1.38
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-18.92.99
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.847-1.17-19.31.61
Financing Cash Flow Items-5.08-5.11
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities77.1640.940.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash53.537.1-37.53.95